Moreover, it was also demonstrated that low doses of DOX when combined with a nanosystem inhibited Notch1 and Ras/MAPK pathways, decreased cancer stem cell population, and reduced tumorigenesis as compared to free DOX in both in vitro and in vivo settings [38]. The gene discussed is NOTCH1; the disease is cancer.